Factors related to alexithymia in patients with systemic sclerosis: a tight relationship with facial image dissatisfaction
- 82 Downloads
To assess clinical and psychosocial factors related to alexithymia in systemic sclerosis (SSc). We enrolled 40 consecutive SSc patients in a cross-sectional study evaluating alexithymia with Toronto Alexithymia scale (TAS-20). We measured Beck Depression inventory (BDI), Hamilton Anxiety rating scale (HAM-H), 36-Items Short-Form Healthy Survey (SF-36), Functional Assessment of Chronic Illness Therapy (FACIT)—Fatigue, Visual Analog Scale (VAS) pain, Pittsburgh Sleep Quality Index (PSQI), Satisfaction with Appearance Scale (SWAP), and Mouth Handicap in Systemic Sclerosis (MHISS). The prevalence of alexithymia was 42%. Alexithymic patients presented increased depressive (p = ≤ 0.001) and anxiety symptoms (p = ≤ 0.001), sleep disorders (p = 0.03), pain (p = 0.02), esthetic concerns (p = 0.03), disability in activities (p = 0.03) and reduced scores of SF-36 in mental components summary (MCS) (p = ≤ 0.001) and physical components summary (PCS) (p = 0.01). We found significant correlations with sleep disorders (r = 0.41, p = ≤ 0.001), BID (r = 0.35, p = 0.04), facial image dissatisfaction (r = 0.35, p = 0.04), mouth disability (r = 0.51, p = 0.005), depressive (r = 0.6, p = ≤ 0.001), and anxiety symptoms (r = 0.48, p = ≤ 0.001), fatigue (r = − 0.45 p = 0.005), SF-36 PCS (r = − 0.51, p = ≤ 0.001) and MCS (r = − 0.65, p = ≤ 0.001). In multiple linear regression analysis, SWAP facial was the only variable associated with TAS-20 [0.99 (0.48) p = 0.05]. Alexithymia correlates with several psychosocial factors but seems strongly related to facial image dissatisfaction.
KeywordsSystemic sclerosis Alexithymia Depression Anxiety Pain QoL
FB was responsible for conceptualization, methodology, data collection, data curation, literature review and article writing. DPEM was responsible for methodology, data curation and formal analysis. CM, VB, GD and PM were responsible for data collection. MV was responsible for literature review, writing and review. AA was responsible for conceptualization, writing, reviewing and editing.
No funding was received for this article.
Compliance with ethical standards
Conflict of interest
Fabio Basta declares he has no conflict of interest, Domenico Paolo Emanuele Margiotta declares he has no conflict of interest, Carmen Mazzuca declares she has no conflict of interest, Veronica Batani declares she has no conflict of interest, Giulio Dolcini declares he has no conflict of interest, Patrizio Moras declares he has no conflict of interest, Marta Vadacca declares she has no conflict of interest, and Antonella Afeltra declares she has no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- 3.Maes F, Sabbe BG (2014) Alexithymia in fibromyalgia: prevalence. Tijdschr Psychiatr 56:798–806Google Scholar
- 6.Basta F, Afeltra A, Margiotta DPE (2018) Fatigue in systemic sclerosis: a systematic review. Clin Exp Rheumatol 36:150–160Google Scholar
- 8.Del Rosso A, Mikhaylova S, Baccini M, Lupi I, Matucci Cerinic M, Maddali Bongi S (2013) In systemic sclerosis, anxiety and depression assessed by hospital anxiety depression scale are independently associated with disability and psychological factors. Biomed Res Int 2013:507493. https://doi.org/10.1155/2013/507493.CrossRefGoogle Scholar
- 9.van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755. https://doi.org/10.1136/annrheumdis-2013-204424.CrossRefGoogle Scholar
- 10.Valentini G, Bencivelli W, Bombardieri S, D’Angelo S, Della Rossa A, Silman AJ et al (2003) European multicentre study to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 62:901–903CrossRefGoogle Scholar
- 20.Sica C, Magni C, Ghisi M et al (2008) Coping orientation to the problems experiences-new Italian version (COPE-NVI). Psicoterapia Cognitiva e Comportamentale 14(1): 27–53Google Scholar
- 23.Maddali Bongi S, Del Rosso A, Miniati I, Galluccio F, Landi G, Tai G, Matucci-Cerinic M (2012) The Italian version of the Mouth Handicap in Systemic Sclerosis scale (MHISS) is valid, reliable and useful in assessing oral health-related quality of life (OHRQoL) in systemic sclerosis (SSc) patients. Rheumatol Int 32:2785–2790. https://doi.org/10.1007/s00296-011-2049-x CrossRefGoogle Scholar
- 24.Ingegnoli F, Galbiati V, Boracchi P, Comi D, Gualtierotti R, Zeni S, Fantini F (2008) Reliability and validity of the Italian version of the hand functional disability scale in patients with systemic sclerosis. Clin Rheumatol 27:743–749. https://doi.org/10.1007/s10067-007-0785-9 CrossRefGoogle Scholar
- 25.Faezi ST, Paragomi P, Shahali A, Akhlaghkhah M, Akbarian M, Akhlaghi M et al (2017) Prevalence and severity of depression and anxiety in patients with systemic sclerosis: an epidemiologic survey and investigation of clinical correlates. J Clin Rheumatol 23:80–86. https://doi.org/10.1097/RHU.0000000000000428.CrossRefGoogle Scholar